PTH and Marchiafava-Bignami disease: Infants diagnosed with MBD in our cohort demonstrated significantly higher levels of both screening and peak ALP and PTH levels compared to infants without MBD, highlighting their utility as early biochemical markers of disturbed bone metabolism.